Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.
Press releases published on August 15, 2025
Liveops Wins 2025 Brandon Hall Group Bronze Award for Best Talent Acquisition Process
Award recognizes Liveops for reimagining the talent acquisition journey to prioritize quality, speed, and alignment. SCOTTSDALE, ARIZONA, AZ, UNITED STATES, August 15, 2025 /EINPresswire.com/ -- Liveops, the leader in flexible customer experience …
rYojbaba Co., Ltd. Announces Closing of $5 Million Initial Public Offering of Japanese Common Shares
FUKUOKA, Japan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”), a Japanese labor consulting and health services company, today announced the closing of its initial public offering of 1,250,000 Japanese …
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
Los Angeles, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (NASDAQ: BSGM), a gold tokenization infrastructure company, today announced the …
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing Australian patent acceptance for the stenoparib DRP® companion diagnostic - Secured new service contract with EU biotech for …
InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa
TAMPA, Fla., Aug. 15, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leader in senior care through the Program of All-inclusive Care for the Elderly (“PACE”), is proud to announce a new joint venture of its Tampa, Florida …
Breeze Holdings Acquisition Corp. Shareholders Approve Business Combination with YD Biopharma Limited
Transaction Expected to Close in the Coming Days Combined Company to be Named YD Bio Limited and Expected to Trade on Nasdaq Under Ticker Symbol “YDES” IRVING, Texas, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Breeze Holdings Acquisition Corp. (“Breeze”) (OTCQX: …
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation
Game changer for stroke, Alzheimer’s, and beyond Shifting from peripheral to tissue-specific oxygenation monitoring BOSTON, MASSACHUSETTS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a pioneering clinical stage …
Recor Medical Responds to the American Heart Association (AHA) and American College of Cardiology’s (ACC) Updated Guidelines on Renal Denervation for the Treatment of Hypertension
Palo Alto, CA, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”), appreciate the American Heart Association (AHA) and American College of Cardiology (ACC) for …
La Croix-Rouge met sur pied un fonds de secours en réponse aux feux de forêt à Terre-Neuve
OTTAWA, Ontario, 15 août 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne lance un appel aux dons au profit du Fonds de secours : Feux de forêt de 2025 à Terre-Neuve-et-Labrador afin de venir en aide aux personnes et aux communautés éprouvées par les …
HeartSciences Announces Conference Participation and Investor Webinar
Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no …
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; BGE-102 demonstrated robust weight loss …
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Innovations in supply chain management and the rise of direct-to-patient models are transforming how life sciences companies execute global clinical trials. The global clinical trial supplies market, …
Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split
FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that …